The changing spectrum of cardiovascular emergencies during the COVID-19 pandemic.

Authors:
Thiele H; Zeymer U.

Journal:
Herz

Publication Year: 2023

DOI:
10.1007/s00059-023-05174-6

PMCID:
PMC10127984

PMID:
37097477

Journal Information

Full Title: Herz

Abbreviation: Herz

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestH. Thiele declares that he has no competing interests. U. Zeymer declares grants and personal fees from Astra Zeneca, grants and personal fees from Bayer, grants and personal fees from BMS, grants and personal fees from Daiichi Sankyo, personal fees from Boehringer Ingelheim, personal fees from Medicines Company, personal fees from Sanofi, personal fees from Ferrer, grants and personal fees from Novartis, outside the submitted work. For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case. Conflict of interest H. Thiele declares that he has no competing interests. U. Zeymer declares grants and personal fees from Astra Zeneca, grants and personal fees from Bayer, grants and personal fees from BMS, grants and personal fees from Daiichi Sankyo, personal fees from Boehringer Ingelheim, personal fees from Medicines Company, personal fees from Sanofi, personal fees from Ferrer, grants and personal fees from Novartis, outside the submitted work."

Evidence found in paper:

"Declarations: Conflict of interestH. Thiele declares that he has no competing interests. U. Zeymer declares grants and personal fees from Astra Zeneca, grants and personal fees from Bayer, grants and personal fees from BMS, grants and personal fees from Daiichi Sankyo, personal fees from Boehringer Ingelheim, personal fees from Medicines Company, personal fees from Sanofi, personal fees from Ferrer, grants and personal fees from Novartis, outside the submitted work.: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case. Conflict of interest: H. Thiele declares that he has no competing interests. U. Zeymer declares grants and personal fees from Astra Zeneca, grants and personal fees from Bayer, grants and personal fees from BMS, grants and personal fees from Daiichi Sankyo, personal fees from Boehringer Ingelheim, personal fees from Medicines Company, personal fees from Sanofi, personal fees from Ferrer, grants and personal fees from Novartis, outside the submitted work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025